{"disease":{"id":"developmental-and-or-epileptic-encephalopathies","name":"developmental and or epileptic encephalopathies"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03166215","title":"Study of TAK-935 as an Adjunctive Therapy in Participants With Developmental and/or Epileptic Encephalopathies","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Takeda","has_results":true},{"nct_id":"NCT07221968","title":"Melatonin for the Treatment of DEE-SWAS","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":3,"lead_sponsor_name":"Hugo W. Moser Research Institute at Kennedy Krieger, Inc.","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}